Utah Medical Products (NASDAQ:UTMD) Stock Price Breaks Below 200-Day Moving Average of $90.62
Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) stock price fell below its 200-day moving average during Monday’s trading. The stock has a 200-day moving average of $90.62 and is trading as low as $83.65. Shares of Utah Medical Products last traded at $83.65, with a volume of 255 shares traded in hands.
Separately, StockNews.com began covering Utah Medical Products in a Thursday, March 31 report. They issued a “Strong Buy” rating for the company.
The stock has a market capitalization of $304.90 million, a P/E ratio of 20.01 and a beta of 0.24. The stock has a 50-day moving average price of $84.88 and a 200-day moving average price of $90.62.
Utah Medical Products (NASDAQ:UTMD – Get Rating) last reported results on Tuesday, April 26. The medical device supplier reported earnings per share of $0.96 for the quarter. The company had revenue of $12.32 million in the quarter. Utah Medical Products had a return on equity of 14.14% and a net margin of 30.34%.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 6. Shareholders of record on Friday, June 17 will receive a dividend of $0.29 per share. The ex-dividend date is Thursday, June 16. This represents an annualized dividend of $1.16 and a dividend yield of 1.39%. Utah Medical Products’ dividend payout ratio (DPR) is currently 27.75%.
In other Utah Medical Products news, Director Barbara A. Payne sold 2,000 shares of the company in a trade on Wednesday, May 11. The stock was sold at an average price of $85.20, for a total value of $170,400.00. Following the sale, the director now directly owns 5,338 shares of the company, valued at $454,797.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders hold 6.60% of the shares of the company.
A number of institutional investors have recently bought and sold shares of UTMD. HealthInvest Partners AB increased its position in Utah Medical Products by 40.0% during the first quarter. HealthInvest Partners AB now owns 56,000 shares of the medical device supplier valued at $5,032,000 after acquiring an additional 16,000 shares in the last quarter. JPMorgan Chase & Co. increased its position in Utah Medical Products shares by 16.9% in the first quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying an additional 14,693 shares last quarter. Ancora Advisors LLC increased its position in Utah Medical Products shares by 51.1% during the first quarter. Ancora Advisors LLC now owns 40,338 shares of the medical device supplier worth $3,494,000 after buying an additional 13,649 shares last quarter. LSV Asset Management purchased a new stake in shares of Utah Medical Products during the first quarter for a value of approximately $1,177,000. Finally, FMR LLC increased its position in Utah Medical Products shares by 2.4% during the first quarter. FMR LLC now owns 488,255 shares of the medical device supplier worth $43,089,000 after purchasing an additional 11,248 shares last quarter. Institutional investors hold 71.44% of the company’s shares.
About Utah Medical Products (NASDAQ:UTMD)
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.
Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.